Other

GSK sees earnings rise amid good demand for vaccines

Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.

Diabetes

One step closer to curing diabetes

A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.

Oncology & Cancer

Using generic cancer drug could save many millions of dollars

With the expiration in January of the patent on Gleevec, the drug that 15 years ago changed chronic myeloid leukemia (CML) from a death sentence to a treatable illness, insurance companies and patients have the opportunity ...

Other

Pfizer beats 3Q expectations, raises 2015 earnings forecast

Pfizer Inc., finally turning the corner after years of generic competition that slashed revenue from the drugmaker's former blockbusters, easily beat Wall Street expectations for the third quarter and raised its 2015 earnings ...

Oncology & Cancer

Patent granted for new technology diagnosing cancer

A new diagnostic technology may significantly improve early detection and treatment of cancer and other diseases. Via a simple blood test the method can potentially diagnose diseases such as cancer at an early stage, enable ...

Medications

Sanofi acquires over-the-counter rights for Cialis

French drugmaker Sanofi is buying the rights to seek approval for a version of the erectile dysfunction drug Cialis that customers would be able to buy without a doctor's prescription.

page 1 from 4